HAM
HZNP

Highstreet Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Highstreet Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$396K Buy
+10,934
New +$335K 0.02% 266

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Highstreet Asset Management's HZNP Position: Q4 2019 in Review

Highstreet Asset Management opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2019: 10,934 shares worth $396K. The stake represents 0.02% of the portfolio and ranks #266 among its holdings.

281 funds tracked by Wall St. Rank hold HZNP as of Q4 2019.

  • Highstreet Asset Management held 10,934 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $396K as of Q4 2019.
  • Horizon Therapeutics Public Limited Company Ordinary Shares was a new Highstreet Asset Management position in Q4 2019.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.02% of Highstreet Asset Management's portfolio in Q4 2019, its #266 holding.
  • 281 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2019.

Based on Highstreet Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.